Hologic, Inc. (HOLX)

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.

The chart shows the growth of an initial investment of $10,000 in Hologic, Inc., comparing it to the performance of the S&P 500 index or another benchmark. All prices have been adjusted for splits and dividends.

Hologic, Inc. (HOLX) has returned 1.48% so far this year and 22.37% over the past 12 months. Over the last ten years, HOLX has returned 8.13% per year, falling short of the S&P 500 Index benchmark, which averaged 12.16% annually.

Based on dividend-adjusted daily data since Jun 21, 1990, HOLX's average daily return is +0.09%, while the average monthly return is +1.69%. At this rate, your investment would double in approximately 3.4 years.

Historically, 55% of months were positive and 45% were negative. The best month was Oct 2001 with a return of +76.2%, while the worst month was Nov 1990 at -49.2%. The longest winning streak lasted 9 consecutive months, and the longest losing streak was 6 months.

On a daily basis, HOLX closed higher 48% of trading days. The best single day was Oct 28, 1991 with a return of +27.3%, while the worst single day was Nov 16, 1990 at -41.7%.

Hologic, Inc. has an annualized alpha of 14.81%, beta of 0.88, and R² of 0.09 versus S&P 500 Index. Calculated based on daily prices since June 22, 1990.

• This stock captured 124.45% of S&P 500 Index gains and 117.52% of its losses — amplifying both gains and losses, but participating more in upside than downside.
• R² of 0.09 means this stock moves largely independently of S&P 500 Index — capture ratios reflect limited market correlation rather than active downside protection. Consider using a more representative benchmark.

HOLX ranks 74 for risk / return — better than 74% of stocks on our site. You're getting solid returns for the risk taken. A good sign, especially for investors who want growth without excessive volatility.

The table below present risk-adjusted performance metrics for Hologic, Inc. (HOLX) and compare them to a chosen benchmark (S&P 500 Index).

The Drawdowns chart displays portfolio losses from any high point along the way. Drawdowns are calculated considering price movements and all distributions paid, if any.

The table below displays the maximum drawdowns of the Hologic, Inc.. A maximum drawdown is a measure of risk, indicating the largest reduction in portfolio value due to a series of losing trades.

The maximum drawdown for the Hologic, Inc. was 93.75%, occurring on Oct 21, 1999. Recovery took 1478 trading sessions.

The current Hologic, Inc. drawdown is 13.78%.

The chart below shows the rolling one-month volatility.

The chart below illustrates the trends in the financial health of Hologic, Inc. over time, highlighting three key metrics: Total Revenue, Earnings Before Interest and Taxes (EBIT), and Net Income.

The Valuation section provides an overview of how Hologic, Inc. is priced in the market compared to other companies in the Medical Instruments & Supplies industry. It includes key financial ratios that help investors assess whether the stock is undervalued or overvalued.